🔗 Visit the ClinicalTrials.gov page for NCT00399802
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Therapeutic targets for bone metastases in breast cancer. | Breast Cancer Res | 2011 | 1.16 |
| 2 | The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial. | Clin Breast Cancer | 2010 | 0.91 |
| 3 | Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes. | Front Chem | 2015 | 0.80 |
| 4 | Alveolar soft part sarcomas: molecular pathogenesis and implications for novel targeted therapies. | Sarcoma | 2012 | 0.80 |